Feasibility of Individualized Therapy for Recurrent Glioblastoma
NCT03681028
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Glioblastoma
Interventions
DRUG:
Individualized therapy
Sponsor
Jennifer Clarke